A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer
Condition(s):Breast CancerLast Updated:December 25, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:December 25, 2012Unknown status
Condition(s):Salivary Gland Cancer; Recurrent Salivary Gland Cancer; Metastatic Cancer; Adenoid Cystic CarcinomaLast Updated:March 22, 2024Active, not recruiting
Condition(s):Metastatic Castrate Resistant Prostate Cancer; BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2; RAD51B, RAD51C, RAD51D, or RAD54L MutationsLast Updated:November 1, 2023Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 25, 2022Not yet recruiting
Condition(s):Ovarian CancerLast Updated:August 12, 2020Completed
Condition(s):Salivary Gland Carcinoma; Adenoid Cystic Carcinoma; Salivary Gland Cancer; Salivary Gland NeoplasmsLast Updated:February 22, 2022Withdrawn
Condition(s):Advanced CancersLast Updated:June 18, 2020Completed
Condition(s):Breast Cancer; Chest Wall DiseaseLast Updated:October 17, 2023Recruiting
Condition(s):GEP-NETLast Updated:May 23, 2022Not yet recruiting
Condition(s):Nonsquamous Nonsmall Cell Neoplasm of LungLast Updated:March 19, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.